Caricamento...

The impact of an aromatase inhibitor on body composition and gonadal hormone levels in women with breast cancer

Aromatase inhibitors (AIs) have become the standard adjuvant therapy of postmenopausal breast cancer survivors. AIs induce a reduction of bioavailable estrogens by inhibiting aromatase, which would be expected to induce alterations in body composition, more extensive than induced by menopause. The o...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: van Londen, G. J., Perera, S., Vujevich, K., Rastogi, P., Lembersky, B., Brufsky, A., Vogel, V., Greenspan, S. L.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2010
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3103776/
https://ncbi.nlm.nih.gov/pubmed/21046232
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-010-1223-2
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !